Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Zai Lab (ZLAB) has issued an update.
Zai Lab Limited has announced the retirement of Dr. Harald Reinhart, Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases, effective June 30, 2024, with no disagreements prompting his departure. Concurrently, Dr. Rafael Amado will take over as Head of Global Research and Development, expanding his current role in Oncology Research, ensuring a seamless transition in leadership.
See more insights into ZLAB stock on TipRanks’ Stock Analysis page.
